⌕
Staar Surgical · STAA · Nasdaq
Tenet 47 · Mixed
Compare
$26.01−1.44%At closeTenet 47 · Mixed
$26.01−0.38 (−1.44%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Staar Surgical (STAA) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 23.7% in FY25, net margin −33.6%. Worth your attention in FY25: Returns vs FCF (n/m). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼23.7%
239.4
FY21→FY25CAGR +1.0%/yr
Net income ($M)▼298.1%
−80.4
one-off year: see footnoteCAGR —
Free cash flow ($M)▼422.2%
−40.0
FY21→FY25CAGR —
Diluted EPS▼295.1%
−1.62
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+0.2%

49.5mn → 49.6mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex
$5.8M

−75.1% YoY in FY25 · 2.4% of revenue.

Returns vs FCF
n/m

$6.5M returned vs $−40.0M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)239.4Revenue−57.0COGS182.4Gross profit−40.1R&D−85.8SG&A−91.7Op income11.3Tax & other−80.4Net income

-34¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~4%FY21FY25

Over this window: gross 77.5% → 76.2%. Net margin -33.6% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
328,269.0239,442.0313,901.0322,415.0284,391.0230,472.0▼23.7%+1.0%
Cost of revenue
86,807.057,022.074,319.069,764.061,008.051,835.0▼23.3%+2.4%
Gross profit
241,462.0182,420.0239,582.0252,651.0223,383.0178,637.0▼23.9%+0.5%
Research & development
39,573.040,055.045,317.040,478.035,983.033,862.0▼11.6%+4.3%
Selling, general & admin
78,253.085,783.089,898.072,319.054,742.044,142.0▼4.6%+18.1%
Total operating expenses
240,761.0274,133.0252,193.0224,554.0179,581.0145,298.0▲8.7%+17.2%
Operating incomefeeds ROC rank
701.0−91,713.0−12,611.028,097.043,802.033,339.0▼627.2%—
Other income, net
4,869.09,450.03,559.05,599.01,750.0−2,035.0——
Pretax income
5,570.0−82,263.0−9,052.033,696.045,552.031,304.0▼808.8%—
Income tax
5,040.0−1,815.011,156.012,349.05,887.03,793.0——
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
530.0−80,448.0−20,208.021,347.039,665.027,511.0▼298.1%—
Per share
Diluted EPSbuyback-sensitive
0.01−1.62−0.410.430.800.56▼295.1%—
Diluted shares (mn)
51.4549.5749.1349.4349.3849.46▲0.9%+0.1%
Margins
Gross margin64th pct in Healthcare
73.6%76.2%76.3%78.4%78.5%77.5%▼0.1pp−1.3pp
Operating margin
0.2%−38.3%−4.0%8.7%15.4%14.5%▼34.3pp−52.8pp
Net margin39th pct in Healthcare
0.2%−33.6%−6.4%6.6%13.9%11.9%▼27.2pp−45.5pp
† TTM = trailing four quarters through 2026-10-02.FY23 effective tax rate was 37% vs a 12% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was −123% vs a 12% norm for this window, likely a one-time item; see the filing.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-03 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Staar Surgical's revenue last fiscal year?

Staar Surgical reported revenue of $239.4M in fiscal 2025, down 23.7% from fiscal 2024.

What was Staar Surgical's net income?

Staar Surgical reported net income of −$80.4M in fiscal 2025, a net margin of −33.6%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.